Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment

BACKGROUND: Fingolimod (FTY) is the first oral medication approved for multiple sclerosis therapy. Until now, little has been known about the effects of FTY withdrawal regarding disease activity and development of tumefactive demyelinating lesions (TDLs), as already described in patients who discont...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ther Adv Neurol Disord
Main Authors: Faissner, Simon, Hoepner, Robert, Lukas, Carsten, Chan, Andrew, Gold, Ralf, Ellrichmann, Gisa
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2015
Fag:
Reviews
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4622113/
https://ncbi.nlm.nih.gov/pubmed/26557898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285615594575
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker